Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders Francesca MariniFrancesca GiustiMaria Luisa Brandi Review 18 August 2022 Pages: 213 - 238
Pharmacist interventions in osteoporosis management: a systematic review Catherine LairdHelen BensonKylie A. Williams Review Open access 14 October 2022 Pages: 239 - 254
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis Safoora PooriraniSayed latif TaheriSayed Abolfazl Mostafavi Review 15 October 2022 Pages: 255 - 267
Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review Konstantinos ParaskevopoulosAnthimos KeskinisAthanasios N. Ververidis Review 12 November 2022 Pages: 269 - 290
Discontinuation of denosumab in men with prostate cancer Anne Sophie SøllingTorben HarsløfBente Langdahl Original Article 19 November 2022 Pages: 291 - 297
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures Benjamin Tze Keong DingHai Fon LimRemesh Kunnasegaran Original Article 21 November 2022 Pages: 299 - 307
Lipopolysaccharide-binding protein and bone health: data from a population-based sample of men Jasmine R. CleminsonJulie A. PascoLana J. Williams Original Article 21 November 2022 Pages: 309 - 317
Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury Michael J. MatthewsKaren L. TroyLeslie R. Morse Original Article 23 November 2022 Pages: 319 - 325
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients Elisabeth NgClaudia AshkarShoshana Sztal-Mazer Original Article 24 November 2022 Pages: 327 - 337
Fracture liaison service model: project design and accreditation U. TarantinoC. GreggiM. L. Brandi Original Article Open access 24 November 2022 Pages: 339 - 348
Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden Bakir O. SumreinHans E. BergTuomas T. Huttunen Original Article Open access 26 November 2022 Pages: 349 - 356
Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging Nazila HassanabadiClaudie BergerSuzanne N. Morin Original Article Open access 30 November 2022 Pages: 357 - 367
Retrospective analyses of clinical features in 28 Chinese patients with type V osteogenesis imperfecta: new perspectives in an old issue Zhijia TanHiu Tung ShekMichael Kai Tsun To Original Article Open access 02 December 2022 Pages: 369 - 377
Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019 Amil R. AgarwalJordan S. CohenGregory J. Golladay Original Article 03 December 2022 Pages: 379 - 385
Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis Po-Wei ChenHsiao-Yuan SuShu-Man Lin Original Article 05 December 2022 Pages: 387 - 397
Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture Ha MaiLynette Mc EvoySteven A. Frost Original Article 06 December 2022 Pages: 399 - 404
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis Pilar PerisAna MonegalEva González-Roca Short Communication 18 November 2022 Pages: 405 - 411
Comments on “Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up” C. LiK. Lu Letter to the Editor 21 November 2022 Pages: 413 - 414
Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up Ilona Nurmi-LüthjeRaine TiihonenPeter Lüthje Letter to the Editor 21 November 2022 Pages: 415 - 416
Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated Yì Xiáng J. Wáng Letter to the Editor 29 November 2022 Pages: 417 - 418
Response to: Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated Pei-Lun XiaoHua-Ding Lu Letter to the Editor 29 November 2022 Pages: 419 - 420
Appropriate dosing of burosumab in tumor-induced osteomalacia Luciano ColangeloChiara SonatoSalvatore Minisola Letter to the Editor 01 December 2022 Pages: 421 - 421
Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia C. CrottiF. ZucchiM. Varenna Letter to the Editor 01 December 2022 Pages: 423 - 424
Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look? M. KaraL. Özçakar Letter to the Editor 05 December 2022 Pages: 425 - 426
Response letter to “sarcopenia, osteoporosis and fractures: what we see” Rebekah J. HarrisNeeta ParimiJane A. Cauley Letter to the Editor 05 December 2022 Pages: 427 - 427
